Form 8-K - Current report:
SEC Accession No. 0001628280-25-018242
Filing Date
2025-04-17
Accepted
2025-04-17 16:52:52
Documents
13
Period of Report
2025-04-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mdgl-20250416.htm   iXBRL 8-K 26568
  Complete submission text file 0001628280-25-018242.txt   153786

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdgl-20250416.xsd EX-101.SCH 1803
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mdgl-20250416_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdgl-20250416_pre.xml EX-101.PRE 13060
15 EXTRACTED XBRL INSTANCE DOCUMENT mdgl-20250416_htm.xml XML 2858
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 25848020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)